These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 8634824)

  • 21. Systematic exploration of the structural features of yatakemycin impacting DNA alkylation and biological activity.
    Tichenor MS; MacMillan KS; Trzupek JD; Rayl TJ; Hwang I; Boger DL
    J Am Chem Soc; 2007 Sep; 129(35):10858-69. PubMed ID: 17691783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.
    Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P
    Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, chemical properties, and biological evaluation of CC-1065 and duocarmycin analogues incorporating the 5-methoxycarbonyl-1,2,9,9a-tetrahydrocyclopropa.
    Boger DL; Hughes TV; Hedrick MP
    J Org Chem; 2001 Apr; 66(7):2207-16. PubMed ID: 11281757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parallel synthesis and evaluation of 132 (+)-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogues of CC-1065 and the duocarmycins defining the contribution of the DNA-binding domain.
    Boger DL; Schmitt HW; Fink BE; Hedrick MP
    J Org Chem; 2001 Oct; 66(20):6654-61. PubMed ID: 11578217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
    Boger DL; Stauffer F; Hedrick MP
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2021-4. PubMed ID: 11454471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysis.
    Boger DL; Santillán A; Searcey M; Brunette SR; Wolkenberg SE; Hedrick MP; Jin Q
    J Org Chem; 2000 Jun; 65(13):4101-11. PubMed ID: 10866627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluation.
    Boger DL; Yun W; Han N
    Bioorg Med Chem; 1995 Nov; 3(11):1429-53. PubMed ID: 8634824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
    Boger DL; Johnson DS
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3642-9. PubMed ID: 7731958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents.
    Patil PC; Satam V; Lee M
    Anticancer Agents Med Chem; 2015; 15(5):616-30. PubMed ID: 25511515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent developments in sequence selective minor groove DNA effectors.
    Reddy BS; Sharma SK; Lown JW
    Curr Med Chem; 2001 Apr; 8(5):475-508. PubMed ID: 11281837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel cyclopropylindole conjugates and dimers: synthesis and anti-cancer evaluation.
    Sharma SK; Jia G; Lown JW
    Curr Med Chem Anticancer Agents; 2001 May; 1(1):27-45. PubMed ID: 12678769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duocarmycins--natures prodrugs?
    Searcey M
    Curr Pharm Des; 2002; 8(15):1375-89. PubMed ID: 12052214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical and biological explorations of the family of CC-1065 and the duocarmycin natural products.
    Ghosh N; Sheldrake HM; Searcey M; Pors K
    Curr Top Med Chem; 2009; 9(16):1494-524. PubMed ID: 19903166
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.